IM Cannabis (IMC) - Premium Medical Cannabis
Pharmaceutical Manufacturing • 
Herzliya, Tel-Aviv District, Israel • 11-20 Employees
Company overview
| Headquarters | Herzliya, Tel-Aviv District, Israel |
| Phone number | +972774442333 |
| Website | |
| NAICS | 3254 |
| SIC | 596 |
| Employees | 11-20 |
| Socials |
Key Contacts at IM Cannabis (IMC) - Premium Medical Cannabis
Anna Taranko
Director Of Marketing And Investor Relations
Eyal Fisher
Chief Executive Officer
IM Cannabis (IMC) - Premium Medical Cannabis Email Formats
IM Cannabis (IMC) - Premium Medical Cannabis uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@imcannabis.com), used 40% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@imcannabis.com | 60% |
{first name} | john@imcannabis.com | 20% |
{first name}.{last name} | john.doe@imcannabis.com | 20% |
About IM Cannabis (IMC) - Premium Medical Cannabis
Premium Medical Cannabis Products for Global Consumers – IM Cannabis (IMC) is one of the world's pioneering medical-grade cannabis companies, with operations in Israel, across Europe, and Canada. Over the past decade, IMC has established its premium medical cannabis brand, comprising a full spectrum of products known for their quality, consistency, and purity, such as 'ROMA', 'TEL AVIV' and 'LONDON'. In Europe, IMC has established a fully operational, vertically integrated medical cannabis business, spearheaded by its EU-GMP certified distribution arm in Germany and augmented by strategic alliances with certified pan-EUGMP certified suppliers. To this end, IMC has formed strong strategic alliances within the international medical cannabis industry, aiming for a dominant position in satisfying the global demand for high-quality medical cannabis products, which both physicians and patients can rely upon. IMC further intends to leverage its expertise in Israel in order to bolster its research and development initiative while collaborating with world-renowned scientists on cutting-edge technology for the benefit of patients around the world To find out about investment opportunities with IMC, please contact [Ben Brownstein] at ben.b@imcannabis.com
IM Cannabis (IMC) - Premium Medical Cannabis revenue & valuation
| Annual revenue | $36,900,000 |
| Revenue per employee | $2,166,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $117,900,000 |
| Total funding | $7,599,999 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
IM Cannabis (IMC) - Premium Medical Cannabis has 9 employees across 6 departments.
Departments
Number of employees
Funding Data
Explore IM Cannabis (IMC) - Premium Medical Cannabis's funding history, including investment rounds, total capital raised, and key backers.
IM Cannabis (IMC) - Premium Medical Cannabis Tech Stack
Discover the technologies and tools that power IM Cannabis (IMC) - Premium Medical Cannabis's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Caching
CDN
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Analytics
UI frameworks
SEO
United States
Singapore
New Zealand
Portugal
AustraliaFrequently asked questions
4.8
40,000 users
